Original Research
Accepted on 20 Aug 2025
Network Meta-Analysis and Cost-Effectiveness Analysis Comparing Cetuximabβ and Cetuximab for Chinese Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer
in Drugs Outcomes Research and Policies
- 166 views